SCHEMBL3860967

SCHEMBL3860967

COc1cccc(C(=O)N2c3cc(F)ccc3-c3ccccc3C2C)c1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
HSD11B1 P28845 1/20 0.46
PTGDR2 Q9Y5Y4 2/20 0.46
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
LMNA P02545 2/20 0.43
HTT P42858 2/20 0.43
TSHR P16473 1/20 0.43
BCHE P06276 2/20 0.43
ACHE P22303 2/20 0.43
HPGD P15428 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3860835 0.92 KMT2A (0.49) ALDH1A1KMT2AMEN1CRHBPCRHR2
SCHEMBL3855301 0.89 GAA (0.44) ALDH1A1KMT2AMEN1CRHBPCRHR2
SCHEMBL3861328 0.87 BCHE (0.52) ALDH1A1KMT2AMEN1CRHBPCRHR2
SCHEMBL3860772 0.86 KMT2A (0.43) KMT2AMEN1
SCHEMBL3855476 0.86 KMT2A (0.43) KMT2AMEN1
SCHEMBL3860822 0.86 KMT2A (0.43) KMT2AMEN1
SCHEMBL3863264 0.85 NPC1 (0.42) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL3857987 0.83 HSD11B1 (0.45) ALDH1A1HSD11B1NPC1RAB9ALMNA
SCHEMBL3860354 0.81 KMT2A (0.46) KMT2AMEN1
SCHEMBL3855280 0.81 ALDH1A1 (0.45) ALDH1A1KMT2AMEN1CRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7585871-B2 4-{[(6R)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; 3-{[(6S)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; 4-{[(6S)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; cytokine expression WYETH (US) 2009-09-08 US disclosed
EP-1784391-A1 PHENANTHRIDINE CARBONYL PHENOLS AS CYTOKINE EXPRESSION MODULATORS Wyeth (US) 2007-05-16 EP disclosed
US-20060058337-A1 Phenanthridine carbonyl phenols WYETH (US) 2006-03-16 US disclosed
WO-2006028875-A1 PHENANTHRIDINE CARBONYL PHENOLS AS CYTOKINE MODULATORS WYETH (US) 2006-03-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060058337-A1 Phenanthridine carbonyl phenols MT-CO2, PAH, CBR3 ALDH1A1 985/4885KMT2A 1282/4885MEN1 3644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.